STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[25-NSE] Xylo Technologies Ltd. American SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
25-NSE
Rhea-AI Filing Summary

Xylo Technologies Ltd. appears on a Nasdaq Form 25 notification indicating removal of a class of its securities from listing and/or registration under Section 12(b) of the Exchange Act. The filing names the issuer, exchange, and the issuer's Israel address and phone number. The form text references the Nasdaq rule provisions for delisting and voluntary withdrawal but does not specify which rule was selected, include a signature, or provide a date, so the precise status and effective details of any removal are not stated.

Positive
  • None.
Negative
  • Key execution details are missing: the form does not show which 17 CFR provision was selected, lacks a signature, and shows no effective date.
  • Unclear delisting status: without the checked rule and authorization details, the filing does not confirm whether the securities have been removed or the withdrawal completed.
  • Insufficient information for investors: no trading suspension dates, no explanation of reasons for removal, and no financial data are provided in this document.

Insights

TL;DR: Form 25 indicates a delisting/withdrawal process for XYLO but critical execution details are missing.

The filing identifies Xylo Technologies Ltd. and Nasdaq as the exchange initiating a Form 25 notification to remove or withdraw a class of securities from Section 12(b) registration. The form references the applicable Nasdaq/SEC rule provisions used for delisting or voluntary withdrawal; however, it lacks the checked rule provision, an authorized signature, and an effective date. Without those elements, the document does not confirm whether the removal was completed, voluntary, or initiated by the exchange. Governance implications depend on the missing details: a completed delisting would materially affect shareholders, while a mere notice of intent would be less definitive.

TL;DR: The filing signals a potential removal from Nasdaq but omits execution specifics needed for market impact assessment.

Form 25 is the procedural instrument to remove a security from Section 12(b) registration. The form supplied lists issuer name, exchange, and contact details, and cites the rule options under 17 CFR 240.12d2-2. Crucially, the form does not indicate which subsection—such as exchange-initiated or issuer-voluntary—was invoked, nor does it show the signed certification or date. Because there are no trading suspension/effective-date details or financial metrics in this filing, one cannot quantify market impact or timing from this document alone.

UNITED STATES
OMB APPROVAL
OMB Number: 3235-0080
Expires: March 31, 2018
Estimated average burden
hours per response: 1.7
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-37381
Issuer: XYLO TECHNOLOGIES LTD
Exchange: Nasdaq Stock Market LLC
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
Address: Omer Industrial Park, No. 7A
P.O. Box 3030
Omer ISRAEL 8496500
Telephone number: (+972) 72 260 2211
(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
American Depositary Shares
(Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
17 CFR 240.12d2-2(a)(1)
17 CFR 240.12d2-2(a)(2)
17 CFR 240.12d2-2(a)(3)
17 CFR 240.12d2-2(a)(4)
Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
2025-08-22 By Tara Petta AVP
Date Name Title
1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the Form 25 filed for XYLO indicate?

The Form 25 notifies that Xylo Technologies Ltd. is the subject of a Nasdaq Form 25 to remove or withdraw a class of securities from Section 12(b) registration, and lists the issuer's address and phone number.

Does the filing state which Nasdaq/SEC rule was used to delist XYLO?

No. The filing references the possible provisions under 17 CFR 240.12d2-2 but does not indicate which specific subsection was selected.

Is there a signature or effective date on the Form 25 for XYLO?

No. The provided content does not include a signed authorization, printed name, title, or a date to confirm filing execution.

Does the document explain why XYLO is being removed from Nasdaq?

No. The content references rule provisions for removal or voluntary withdrawal but contains no explanation or factual reasons for the action.

Where is Xylo Technologies Ltd. located according to the filing?

The filing lists the issuer's principal executive offices at Omer Industrial Park, No. 7A P.O. Box 3030 Omer, Israel 8496500, with telephone (+972) 72 260 2211.
Xylo Technologies

NASDAQ:XYLO

XYLO Rankings

XYLO Latest News

XYLO Latest SEC Filings

XYLO Stock Data

6.49M
1.17M
9.05%
5.84%
1.01%
Medical Devices
Healthcare
Link
Israel
Tel Aviv